The neurological complications of Epstein-Barr virus infection include vira
l meningitis, encephalitis and neuromuscular complications. The introductio
n of cerebrospinal fluid polymerase chain reaction for Epstein-Barr virus D
NA has improved diagnosis of these conditions and of primary central nervou
s system lymphoma in acquired immune deficiency syndrome, and has enabled c
erebrospinal fluid monitoring of therapy. Prognosis remains good for most E
pstein-Barr virus-related neurological complications; for primary central n
ervous system lymphoma in acquired immune deficiency syndrome the prognosis
is still poor. Curl Opin Neurol 13:301-304 (C) 2000 Lippincott Williams &
Wilkins.